Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?

Briggs AH, Claxton K, Sculpher MJ. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006. National Institute for Health and Care Excellence: Guide to the methods of technology appraisal. Process and methods guides, https://www.nice.org.uk/process/pmg9. 2013. CADTH: Procedures for CADTH Reimbursement Reviews. https://cadth.ca/sites/default/files/Drug_Review_Process/CADTH_Drug_Reimbursement_Review_Procedures.pdf. 2021. Welton NJ, Sutton AJ, Cooper NJ, Abrams KR, Ades AE: Evidence Synthesis for Decision Making in Healthcare: John Wiley and Sons; 2012. Mood AM, Graybill FA, Boes DC: Introduction to the Theory of Statistics: Third Edition: McGraw-Hill International Editions; 1974. Jensen JLWV. Sur les fonctions convexes et les inégalités entre les valeurs moyennes. Acta Math. 1906;30(1):175–93. NICE: TA607: Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease. https://www.nice.org.uk/guidance/ta607. 2019. Wilson ECF. Methodological note: reporting deterministic versus probabilistic results of markov, partitioned survival and other non-linear models. Appl Health Econ Health Policy. 2021;19(6):789–95. Incerti D, Thom H, Baio G, Jansen JP. R you still using excel? the advantages of modern software tools for health technology assessment. Value Health. 2019;22(5):575–9. R Core Team: R: A Language and Environment for Statistical Computing. https://www.R-project.org/. Vienna, Austria: R Foundation for Statistical Computing; 2019.